Piperacillin and Tazobactam Injection shortage
To Be DiscontinuedPiperacillin and Tazobactam Injection is currently listed as To Be Discontinued in the FDA Drug Shortage Database. Reported reason: Not specified.
Therapeutic category
Dosage form
Injection
Routes
INTRAVENOUS
Last updated
01/20/2026
Strength variants
- Not specified
Need sourcing help for Piperacillin and Tazobactam Injection?
Get connected with licensed distributors and 503B compounders that can fulfill orders during active shortages. Verified suppliers, no spam.
Connect with a sourcing partnerManufacturers reporting shortage
- Fresenius Kabi USA, LLC888-386-1300To Be Discontinued
Reason for shortage
ad slot 300x250
Related shortages in Anti-Infective
Rifampin Capsule
- Category
- Anti-Infective
- Reason
- Not specified
- Updated
- 04/08/2026
Rifampin Capsule
- Category
- Anti-Infective
- Reason
- Discontinuation of the manufacture of the drug
- Updated
- 04/08/2026
Rifampin Capsule
- Category
- Anti-Infective
- Reason
- Discontinuation of the manufacture of the drug
- Updated
- 04/08/2026
Rifampin Capsule
- Category
- Anti-Infective
- Reason
- Discontinuation of the manufacture of the drug
- Updated
- 04/08/2026
Rifampin Capsule
- Category
- Anti-Infective
- Reason
- Not specified
- Updated
- 04/08/2026
Rifampin Capsule
- Category
- Anti-Infective
- Reason
- Discontinuation of the manufacture of the drug
- Updated
- 04/08/2026
This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.